Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 19 unusual trades. Delving into the details, we found 42% of ...

Deep-pocketed investors have adopted a bearish approach towards Moderna (NASDAQ:MRNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

Moderately bullish activity in Moderna (MRNA), with shares up 96c, or 3.11%, near $31.82. Options volume running well above average with 111k ...

Mixed options sentiment in Moderna (MRNA), with shares down 20c near $30.95. Options volume roughly in line with average with 54k contracts traded ...

Analysts have soured on Moderna's prospects, despite recent good news in its drug pipeline. This put spread strategy risks $4.53 to make $0.47 in 121 days. The full premium is earned if MRNA remains ...

Deep-pocketed investors have adopted a bullish approach towards Moderna (NASDAQ:MRNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna. Looking at options history for Moderna MRNA we detected 13 trades. If we consider the specifics of each trade, it ...

After donating $176 million in proceeds from his original stock options in 2023, Stéphane Bancel is taking a different path with his next tranche of options that expire in February 2026.